Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline

Kyung Jin Min, Sang Hoon Kwon, Sunghoon Kim, Hyun Jung Kim, Seok Ju Seong, Yong Jung Song, Jin Woo Shin, Keun Ho Lee, Myong Cheol Lim, Hyun Hoon Chung, Woong Ju, Jin Hwa Hong, Jeong Won Lee, Jae Weon Kim, Duk Soo Bae, Jae Kwan Lee

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.

Original languageEnglish
Article numbere30
JournalJournal of Gynecologic Oncology
Issue number3
StatePublished - May 2016

Bibliographical note

Publisher Copyright:
© 2016. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.


  • Human papillomavirus vaccine
  • Uterine cervical neoplasms


Dive into the research topics of 'Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline'. Together they form a unique fingerprint.

Cite this